
A 39 year-old man with malaria due to Plasmodium falciparum received 3500 mg mefloquine over 3 days, in addition to 3250 mg chloroquine and 175/3500 mg sulfadoxine/pyrimethamine. He developed severe neuropsychiatric symptoms and had to be hospitalized. Treatment with diazepam, haloperidol and thioridazine achieved relief of the severe symptoms after 4 days. The patient was still suffering from discrete neuropsychiatric symptoms 8 months after treatment.
Adult, Male, Diazepam, Dose-Response Relationship, Drug, Thioridazine, Drug Administration Schedule, Psychoses, Substance-Induced, Mefloquine, Pyrimethamine, Sulfadoxine, Haloperidol, Humans, Drug Therapy, Combination, Malaria, Falciparum
Adult, Male, Diazepam, Dose-Response Relationship, Drug, Thioridazine, Drug Administration Schedule, Psychoses, Substance-Induced, Mefloquine, Pyrimethamine, Sulfadoxine, Haloperidol, Humans, Drug Therapy, Combination, Malaria, Falciparum
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 7 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
